News

Dr George Tidmarsh, a former pharmaceutical executive who joined the FDA this month, will take over Prasad’s role temporarily.
Empaveli approved to treat two rare kidney diseases; Elevidys available again for ambulatory patients; Mounjaro shows benefit in cardiovascular disease; ...
Increase in theta-beta ratio seen after treatment, correlating with improved cognitive inhibition. HealthDay News — Treatment of traumatic brain injury with magnesium-ibogaine reduces spatiotemporal ...
SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.
Effectiveness seen for RSV lower respiratory tract disease, hospitalized RSV lower respiratory tract disease, PCR-confirmed RSV.
Fracture risk then decreases to levels similar to and then lower than women who have never used menopausal hormone therapy.
On issues such as vaccination and fluoridation of public water supplies, some of Monarez’s comments appeared to be at odds with those of Health and Human Services Secretary Robert F. Kennedy Jr.
HealthDay News — In an effort to broaden the reach of the organization, the Leukemia & Lymphoma Society (LLS) has announced they are changing their name to Blood Cancer United.
The wearable, noninvasive CardioTag is designed to capture electrocardiogram, photoplethysmogram, and seismocardiogram signals, as well as heart rate and pulse rate.
Jacek Skarbinski, MD, from Oakland Medical Center in California, and colleagues assessed COVID-19 vaccine effectiveness (VE) and the number needed-to-vaccinate (NNV) among people with cancer. The ...
CLL-314 trial compared the efficacy and safety of pirtobrutinib with ibrutinib in adults with CLL/SLL who were treatment-naïve or who were previously treated and were BTK inhibitor-naïve.
The public appears to have reservations about the integration of artificial intelligence (AI) in US health care, according to a research letter published online July 17 in JAMA Network Open. Moritz ...